Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance?

Metabolism: Clinical and Experimental

Volumn 59, Issue 6, 2010, Pages 861-865

  Eynon, Nir ^a   Alves, Alberto Jorge ^b   Meckel, Yoav ^a   Yamin, Chen ^a   Ayalon, Moshe ^a   Sagiv, Michael ^a   Sagiv, Moran ^a  

^a The Zinman College of Physical Education and Sports Sciences at the Wingate Institute   (Israel)

^b Research Centre in Physical Activity   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; ARTICLE; ATHLETE; ATHLETIC PERFORMANCE; CONTROLLED STUDY; ENDURANCE SPORT; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; ISRAEL; MALE; MARATHON RUNNER; PRIORITY JOURNAL;

ACTININ; ADULT; ALLELES; ATHLETIC PERFORMANCE; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; RUNNING;

EID: 77952263507     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.10.003     Document Type: Article

References (22)

1. Druzhevskaya A.M., Ahmetov I.I., Astratenkova I.V., et al. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol 103 (2008) 631-634
2. Eynon N., Duarte J.A., Oliveira J., et al. ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sports Med 30 (2009) 695-698
3. Papadimitriou I.D., Papadopoulos C., Kouvatsi A., et al. The ACTN3 gene in elite Greek track and field athletes. Int J Sports Med 29 (2008) 352-355
4. Yang N., MacArthur D.G., Gulbin J.P., et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73 (2003) 627-631
5. Nazarov I.B., Woods D.R., Montgomery H.E., et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 9 (2001) 797-801
6. Woods D., Hickman M., Jamshidi Y., et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 108 (2001) 230-232
7. Amir O., Amir R., Yamin C., et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol 92 (2007) 881-886
8. Gomez-Gallego F, Ruiz JR, Buxens A, et al. The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports. Eur J Appl Physiol (in press).
9. Ruiz J, Buxens A, Artieda M, et al. The -174 G/C polymorphism of the IL6 gene is associated with elite power performance. J Sci Med Sport (in press).
10. Iyer N.V., Kotch L.E., Agani F., et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12 (1998) 149-162
11. Jiang B.H., Semenza G.L., Bauer C., et al. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271 (1996) C1172-C1180
12. Airley R.E., and Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53 (2007) 233-256
13. Pisani D.F., and Dechesne C.A. Skeletal muscle HIF-1alpha expression is dependent on muscle fiber type. J Gen Physiol 126 (2005) 173-178
14. Clifford S.C., Astuti D., Hooper L., et al. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 20 (2001) 5067-5074
15. Ahmetov I.I., Hakimullina A.M., Lyubaeva E.V., et al. Effect of HIF1A gene polymorphism on human muscle performance. Bull Exp Biol Med 146 (2008) 351-353
16. Tanimoto K., Yoshiga K., Eguchi H., et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24 (2003) 1779-1783
17. Spencer M.R., and Gastin P.B. Energy system contribution during 200- to 1500-m running in highly trained athletes. Med Sci Sports Exerc 33 (2001) 157-162
18. Chanock S.J., Manolio T., Boehnke M., et al. Replicating genotype-phenotype associations. Nature 447 (2007) 655-660
19. Hlatky M.A., Quertermous T., Boothroyd D.B., et al. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J 154 (2007) 1035-1042
20. Moran C.N., Yang N., Bailey M.E., et al. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet 15 (2007) 88-93
21. van Rooij E., Marshall W.S., and Olson E.N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 103 (2008) 919-928
22. Macarthur D.G., and North K.N. Genes and human elite athletic performance. Hum Genet 116 (2005) 331-339